Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Tips for Exploring Tough Topics with Teens with Rheumatic Disease

Susan Bernstein  |  Issue: January 2020  |  January 17, 2020

Ms. Pagano

Ms. Pagano

Eileen Pagano, MS, CPNP, a pediatric rheumatology nurse practitioner at Cohen’s Children Medical Center, shared the story of her patient, “Kate,” who was diagnosed with oligoarticular juvenile idiopathic arthritis at age 2 and uveitis in both eyes a year later. Kate’s therapy included joint injections, methotrexate and eye drops, and she developed persistent sleep problems. Between 8 and 14, she had regular infliximab infusions.

“As she grew up, developed and began menstruating, Kate had a surge of hormones that fueled all these behaviors that Dr. Gottlieb discussed, and this went on for about two to three years. It was a tricky time for her,” said Ms. Pagano. “She had a lot of difficulty sleeping, and she began displaying aggressive behavior at home toward her parents and her siblings.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

At 14, Kate was diagnosed with oppositional defiant disorder, and her rheumatology care team discontinued infliximab because of concerns about its potential cognitive side effects, said Ms. Pagano. At 15, Kate started intravenous abatacept treatment at home through a home health service, which controlled her disease but caused mouth sores. At 16, Kate’s cousin committed suicide, which disturbed the teenager, and she experienced an iritis flare. Kate’s methotrexate dose was increased, but by 16, she began missing doses and began binge drinking. She began vaping nicotine daily at 17, and continued abatacept infusions once she started college at 18. Kate had an abortion at 19, and later withdrew from school and quit taking all of her medications. Her arthritis flared. Now 22, Kate has stabilized her mental health with counseling, and after working two jobs to pay for her tuition, is now thriving at a new college.

“Kate was drinking at an early age and binge drinking often, although it was contraindicated with her methotrexate. Look at the reason for the child’s drinking. Kate chose alcohol because it was an effective anti-anxiety agent,” said Ms. Pagano. A regular exercise routine and counseling helped this patient deal with stress and improve her sleep over time.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Establishing a rapport with your kids very early on so that you can take them through their adolescence is the most important advice. You’re not their parent, you’re not their friend, but make it clear that they can talk to you and that they can trust you,” she said. 


Susan Bernstein is a freelance journalist based in Atlanta.

References

  1. Monitoring the future: 2018 study results. National Institute on Drug Abuse, National Institutes of Health..
  2. Kann L, McManus T, Harris WA, et al. Youth risk behavior surveillance—United States, 2017. MMWR Surveill Summ. 2018 Jun 15;67(8):1–114.
  3. Abma JC, Martinez GM. Sexual activity and contraceptive use among teenagers in the United States: 2011–2015. Natl Health Stat Report. 2017 Jun 22;(104):1–23.

Page: 1 2 3 | Single Page
Share: 

Filed under:Patient PerspectivePresident's Perspective Tagged with:2019 ACR/ARP Annual MeetingLGBTQPediatric Rheumatology

Related Articles

    Old Drugs Can Learn New Tricks

    November 1, 2011

    Methotrexate and its mechanism of action

    ACR/ARHP Annual Meeting 2012: Rheumatologists Take Proactive Approach in Talking with Teen Patients about Risky Behavior

    February 1, 2013

    With teenaged juvenile arthritis patients, it’s important for rheumatologists to engage in conversations about how drugs, tobacco, alcohol, and sex will affect them

    Tips for Transitioning Patients from Pediatric to Adult Rheumatology Care

    October 14, 2021

    Approximately 50% of young adult patients with childhood-onset rheumatic diseases become lost to follow-up within the first year of transferring to adult rheumatology care, mirroring the statistics of other subspecialties.1,2 One of the challenges cited most consistently by young adult patients and their families relates to differences between rheumatology care delivery in the pediatric and…

    Minerals, Mud, Martinis, and Methylprednisone

    June 10, 2012

    How the practice of rheumatology differs in America and Europe.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences